Home > > > Report Detail

Global Gene Therapy for Age-related Macular Degeneration Market Research Report 2023

Publisher Name :
Date: 07-Feb-2023
No. of pages: 67
Inquire Before Buying

Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is directly related to the advancement of age. But smoking also plays a vital role in causing AMD. AMD is characterized by the presence of a blurred area near the center of vision that leads to distorted vision. There are two different types of AMD, including dry (atrophic) AMD (dAMD) and wet (neovascular/exudative) AMD (wAMD). The dAMD is the most common type of AMD and accounts for almost 80%-90% of the overall AMD cases.

Highlights

The global Gene Therapy for Age-related Macular Degeneration market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

It has been observed that age-related macular degeneration (AMD) is one of the major causes for vision loss and is characterized by the formation of a blurred area near the center of vision, a condition that mostly affects the geriatric population. According to the CDC, almost 2 million individuals in the US suffer from AMD and by 2050, this number will reach more than 5 million. This will subsequently demand the need for the development of innovative treatments for AMD, driving the market's growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gene Therapy for Age-related Macular Degeneration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy for Age-related Macular Degeneration.

The Gene Therapy for Age-related Macular Degeneration market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gene Therapy for Age-related Macular Degeneration market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy for Age-related Macular Degeneration companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- RetroSense Therapeutics

- REGENXBIO

- AGTC

Segment by Type

- Subretinal

- Intravitreal

Segment by Application

- Monotherapy

- Combination Therapy

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gene Therapy for Age-related Macular Degeneration companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Gene Therapy for Age-related Macular Degeneration Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Subretinal
1.2.3 Intravitreal
1.3 Market by Application
1.3.1 Global Gene Therapy for Age-related Macular Degeneration Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Monotherapy
1.3.3 Combination Therapy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy for Age-related Macular Degeneration Market Perspective (2018-2029)
2.2 Gene Therapy for Age-related Macular Degeneration Growth Trends by Region
2.2.1 Global Gene Therapy for Age-related Macular Degeneration Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy for Age-related Macular Degeneration Historic Market Size by Region (2018-2023)
2.2.3 Gene Therapy for Age-related Macular Degeneration Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy for Age-related Macular Degeneration Market Dynamics
2.3.1 Gene Therapy for Age-related Macular Degeneration Industry Trends
2.3.2 Gene Therapy for Age-related Macular Degeneration Market Drivers
2.3.3 Gene Therapy for Age-related Macular Degeneration Market Challenges
2.3.4 Gene Therapy for Age-related Macular Degeneration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy for Age-related Macular Degeneration Players by Revenue
3.1.1 Global Top Gene Therapy for Age-related Macular Degeneration Players by Revenue (2018-2023)
3.1.2 Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy for Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy for Age-related Macular Degeneration Revenue
3.4 Global Gene Therapy for Age-related Macular Degeneration Market Concentration Ratio
3.4.1 Global Gene Therapy for Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Age-related Macular Degeneration Revenue in 2022
3.5 Gene Therapy for Age-related Macular Degeneration Key Players Head office and Area Served
3.6 Key Players Gene Therapy for Age-related Macular Degeneration Product Solution and Service
3.7 Date of Enter into Gene Therapy for Age-related Macular Degeneration Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Age-related Macular Degeneration Breakdown Data by Type
4.1 Global Gene Therapy for Age-related Macular Degeneration Historic Market Size by Type (2018-2023)
4.2 Global Gene Therapy for Age-related Macular Degeneration Forecasted Market Size by Type (2024-2029)
5 Gene Therapy for Age-related Macular Degeneration Breakdown Data by Application
5.1 Global Gene Therapy for Age-related Macular Degeneration Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy for Age-related Macular Degeneration Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Therapy for Age-related Macular Degeneration Market Size (2018-2029)
6.2 North America Gene Therapy for Age-related Macular Degeneration Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023)
6.4 North America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy for Age-related Macular Degeneration Market Size (2018-2029)
7.2 Europe Gene Therapy for Age-related Macular Degeneration Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023)
7.4 Europe Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size (2018-2029)
8.2 Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy for Age-related Macular Degeneration Market Size (2018-2029)
9.2 Latin America Gene Therapy for Age-related Macular Degeneration Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023)
9.4 Latin America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size (2018-2029)
10.2 Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 RetroSense Therapeutics
11.1.1 RetroSense Therapeutics Company Detail
11.1.2 RetroSense Therapeutics Business Overview
11.1.3 RetroSense Therapeutics Gene Therapy for Age-related Macular Degeneration Introduction
11.1.4 RetroSense Therapeutics Revenue in Gene Therapy for Age-related Macular Degeneration Business (2018-2023)
11.1.5 RetroSense Therapeutics Recent Development
11.2 REGENXBIO
11.2.1 REGENXBIO Company Detail
11.2.2 REGENXBIO Business Overview
11.2.3 REGENXBIO Gene Therapy for Age-related Macular Degeneration Introduction
11.2.4 REGENXBIO Revenue in Gene Therapy for Age-related Macular Degeneration Business (2018-2023)
11.2.5 REGENXBIO Recent Development
11.3 AGTC
11.3.1 AGTC Company Detail
11.3.2 AGTC Business Overview
11.3.3 AGTC Gene Therapy for Age-related Macular Degeneration Introduction
11.3.4 AGTC Revenue in Gene Therapy for Age-related Macular Degeneration Business (2018-2023)
11.3.5 AGTC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Subretinal
Table 3. Key Players of Intravitreal
Table 4. Global Gene Therapy for Age-related Macular Degeneration Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy for Age-related Macular Degeneration Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy for Age-related Macular Degeneration Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gene Therapy for Age-related Macular Degeneration Market Share by Region (2018-2023)
Table 8. Global Gene Therapy for Age-related Macular Degeneration Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy for Age-related Macular Degeneration Market Share by Region (2024-2029)
Table 10. Gene Therapy for Age-related Macular Degeneration Market Trends
Table 11. Gene Therapy for Age-related Macular Degeneration Market Drivers
Table 12. Gene Therapy for Age-related Macular Degeneration Market Challenges
Table 13. Gene Therapy for Age-related Macular Degeneration Market Restraints
Table 14. Global Gene Therapy for Age-related Macular Degeneration Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gene Therapy for Age-related Macular Degeneration Market Share by Players (2018-2023)
Table 16. Global Top Gene Therapy for Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Age-related Macular Degeneration as of 2022)
Table 17. Ranking of Global Top Gene Therapy for Age-related Macular Degeneration Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene Therapy for Age-related Macular Degeneration Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy for Age-related Macular Degeneration Product Solution and Service
Table 21. Date of Enter into Gene Therapy for Age-related Macular Degeneration Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy for Age-related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share by Type (2018-2023)
Table 25. Global Gene Therapy for Age-related Macular Degeneration Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy for Age-related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share by Application (2018-2023)
Table 29. Global Gene Therapy for Age-related Macular Degeneration Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share by Application (2024-2029)
Table 31. North America Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 46. RetroSense Therapeutics Company Detail
Table 47. RetroSense Therapeutics Business Overview
Table 48. RetroSense Therapeutics Gene Therapy for Age-related Macular Degeneration Product
Table 49. RetroSense Therapeutics Revenue in Gene Therapy for Age-related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 50. RetroSense Therapeutics Recent Development
Table 51. REGENXBIO Company Detail
Table 52. REGENXBIO Business Overview
Table 53. REGENXBIO Gene Therapy for Age-related Macular Degeneration Product
Table 54. REGENXBIO Revenue in Gene Therapy for Age-related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 55. REGENXBIO Recent Development
Table 56. AGTC Company Detail
Table 57. AGTC Business Overview
Table 58. AGTC Gene Therapy for Age-related Macular Degeneration Product
Table 59. AGTC Revenue in Gene Therapy for Age-related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 60. AGTC Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy for Age-related Macular Degeneration Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gene Therapy for Age-related Macular Degeneration Market Share by Type: 2022 VS 2029
Figure 3. Subretinal Features
Figure 4. Intravitreal Features
Figure 5. Global Gene Therapy for Age-related Macular Degeneration Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gene Therapy for Age-related Macular Degeneration Market Share by Application: 2022 VS 2029
Figure 7. Monotherapy Case Studies
Figure 8. Combination Therapy Case Studies
Figure 9. Gene Therapy for Age-related Macular Degeneration Report Years Considered
Figure 10. Global Gene Therapy for Age-related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Gene Therapy for Age-related Macular Degeneration Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Gene Therapy for Age-related Macular Degeneration Market Share by Region: 2022 VS 2029
Figure 13. Global Gene Therapy for Age-related Macular Degeneration Market Share by Players in 2022
Figure 14. Global Top Gene Therapy for Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Age-related Macular Degeneration as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy for Age-related Macular Degeneration Revenue in 2022
Figure 16. North America Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Gene Therapy for Age-related Macular Degeneration Market Share by Country (2018-2029)
Figure 18. United States Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Gene Therapy for Age-related Macular Degeneration Market Share by Country (2018-2029)
Figure 22. Germany Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy for Age-related Macular Degeneration Market Share by Region (2018-2029)
Figure 30. China Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Gene Therapy for Age-related Macular Degeneration Market Share by Country (2018-2029)
Figure 38. Mexico Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy for Age-related Macular Degeneration Market Share by Country (2018-2029)
Figure 42. Turkey Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Gene Therapy for Age-related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. RetroSense Therapeutics Revenue Growth Rate in Gene Therapy for Age-related Macular Degeneration Business (2018-2023)
Figure 45. REGENXBIO Revenue Growth Rate in Gene Therapy for Age-related Macular Degeneration Business (2018-2023)
Figure 46. AGTC Revenue Growth Rate in Gene Therapy for Age-related Macular Degeneration Business (2018-2023)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs